Concepedia

Publication | Closed Access

Skin and Nail Responses after 1 Year of Infliximab Therapy in Patients with Moderate-to-Severe Psoriasis: A Retrospective Analysis of the EXPRESS Trial

DOI

59

Citations

11

References

2010

Year

Kristian Reich, Jean-Paul Ortonne, Urs Kerkmann, Yanxin Wang, J.‐H. Saurat, Kim Papp, Richard G. Langley, C.E.M. Griffiths
Dermatology

Abstract

Infliximab treatment for 1 year produced sustained improvement in PASI, DLQI and NAPSI scores.

References

YearCitations

Page 1